1 |
Hu J, Yang Y, Ma Y, Ning Y, Chen G, Liu Y. Proliferation Cycle Transcriptomic Signatures are Strongly associated With Gastric Cancer Patient Survival. Front Cell Dev Biol 2021;9:770994. [PMID: 34926458 DOI: 10.3389/fcell.2021.770994] [Reference Citation Analysis]
|
2 |
Xu Z, Wang S, Ren Z, Gao X, Xu L, Zhang S, Ren B. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02543-z] [Reference Citation Analysis]
|
3 |
Chen Q, Yang S, Zhang Y, Li B, Xu H, Zuo S, Yang Z. Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/9868022] [Reference Citation Analysis]
|
4 |
Tahoun A, El-Sharkawy H, Moustafa SM, Abdel-Hafez LJM, Albrakati A, Koegl M, Haas J, Mahajan A, Gally DL, Elmahallawy EK. Mitotic Arrest-Deficient 2 Like 2 (MAD2L2) Interacts with Escherichia coli Effector Protein EspF. Life (Basel) 2021;11:971. [PMID: 34575120 DOI: 10.3390/life11090971] [Reference Citation Analysis]
|
5 |
Xing J, Chen M, Han Y. . MBE 2022;19:5905-24. [DOI: 10.3934/mbe.2022276] [Reference Citation Analysis]
|